Abstract:
This invention pertains to methods of [ 11 C]-radiolabelling "phenothiazine" and "phenothiazine-like" compounds, which have a pendant group (which is a primary amino group; a cationic primary imino group; a secondary amino group; a cationic secondary imino group; a primary imino group; or a secondary imino group), by reaction with [ 11 C]methyl trifluoromethanesulfonate (CF 3 SO 2 O 11 CH 3 ), also known as [ 11 C]methyl triflate. This reaction converts the pendant group into a [ 11 C]methyl-labelled pendant group. The resulting [ 11 C]-radiolabelling product is useful, for example, as an in vivo positron emission tomography (PET) tracer, for example, for patients suffering from melanoma, the most serious form of skin cancer, and tauopathy (e.g., Alzheimer's disease). The present invention also pertains to the resulting [ 11 C]-radiolabelling products, compositions comprising them, their use in methods of (e.g., PET) imaging, their use in methods of medical treatment and diagnosis, etc.
Abstract:
Methods for inhibiting the microbiologically influenced corrosion of a metal are provided comprising treating the surface of the metal with a microbiologically influenced corrosion inhibiting effective amount of a source of rare earth metal ions; wherein the surface of the metal is in the presence of corrosive reagents such as chloride ions and acids and one or more microorganisms capable of colonizing on and/or embedding into the surface and preventing self-healing of the surface of the metal damaged by the corrosive reagents.
Abstract:
Antisense compounds, compositions, and methods are provided for modulating the expression of acyl-Coa synthesis 1, heretofore referred to as ACS1. The compositions comprise antisense compounds, particulary antisense oligonucleotides, targeted to nucleic acids encoding ACS1. Methods of using these compounds for modulation of ACS1 expression and for treatment of diseases associated with expression of ACS1 are provided.
Abstract:
The present invention is directed to production of a molecule having a predetermined property. In accordance with one embodiment, a library of initial candidate molecules that are at least somewhat dissimilar to a chosen target molecule or "targetshape" is generated. Variants of the initial candidates are generated and screened to identify intermediate candidates from among those variants that are either more or less similar to the targetshape. Data mining techniques such as neural networks are used to extract information about the molecule structures and shapes which lead to the desired activity. Molecular data bases may be screened for candidates matching the preferred shape description or molecules matching the preferred shape description may be synthesized. The process may be iterated by generating variants of the intermediate candidates and screening these variants to identify molecules futher more or less similar to the targetshape.
Abstract:
A purified IceA protein of Helicobacter pylori is provided. The protein is expressed as either an IceA 1 or an IceA 2 variant. A purified polypeptide fragment of the IceA protein is also provided. An antigenic fragment of IceA is provided. An isolated nucleic acid that encodes an IceA protein of H. pylori is provided. A nucleic acid that encodes an IceA 1 variant and a nucleic acid that encodes an IceA 2 variant is also provided. Fragments of the IceA gene are provided. A method of detecting the presence of an antibody against H. pylori in a sample is provided. The method comprises the following steps: a) contacting the sample with a purified IceA protein of H. pylori or a H. pylori-specific fragment thereof; and b) detecting the binding of the antibody in the sample to the protein or fragment, the detection of biding indicating the presence in the sample of antibodies against H. pylori. A method of detecting the presence of an antibody against an ulcerative Helicobacter pylori strain in a sample is also provided.
Abstract:
Methods for the generation of new compounds are disclosed. The present invention eliminates the need to know in advance the structure or chemical composition of a compound having a desired property. The disclosure of the present invention provides that diversity of unknown compounds may be produced by "random" chemistry, and such a diversity of unknown compounds may be screened for one or more desired properties to detect the presence of suitable compounds. In one aspect, a starting group of organic compounds is caused to undergo a series of chemical reactions to create a diversity of new organic compounds that are screened for the presence of organic compounds having the desired property. In another aspect of the present invention, a diversity of compounds is generated from a group of substrates which are subjected to a group of enzymes representing a diversity of catalytic activities.
Abstract:
Method and apparatus to enhance intermodal containers (10) for transport of vehicles wherein multiple longitudinal rails (14) on container walls support movable and removable transverse cargo pallets (16) having foot members (18) which are articulatably connected to the pallets. Cargo, preferably an automobile fixed to front and rear pallets, is loaded by inserting each pallet's feet onto appropriate rail(s) at door opening, then sliding to stowage spot, the rail selection determining height and tilt. Stowage of any mix of automobiles in intermodal containers is optimized by double-decking, half-decking, double half-decking, mirror-imaging, and envelope intervention. On back haul, pallets serve other cargo as restraints, hangers, pallets, or dunnage deck supports, or they are stowed out of the way. Method and apparatus permit automated load planning and container stuffing and make containerized shipment of large volumes of automobiles cost competitive with current methods.
Abstract:
Disclosed herein are methods for treating juvenile onset neurological conditions, such as autism (ASD), intellectual disability, or epilepsy, with an inhibitor of N-methyl-D-aspartate receptor (NMDAR). The inhibitor may be NitroSynapsin or a derivative thereof.
Abstract:
The present disclosure provides a method of producing a personalized medical record, comprising: sensing capabilities of a receiving device; retrieving stock information; retrieving personalized information; combining at least a portion of the stock information and at least a portion of the personalized information into the personalized record; formatting the personalized record based on a combination of the capabilities of the receiving device and a user's preference; and, transmitting the formatted personalized record to the device.